Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Rustin

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
British Journal of Cancer|October 25, 2000
Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumoursM P Napier, A Naraghi, T J Christmas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 1, 1997
FaFEC: a novel regimen for advanced ovarian cancerM Bower, K Goodchild, H Evans, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Treatment of advanced malignant melanoma with interferon alpha and etretinateG J Rustin, S Dische, S T de Garis, et al.
British Medical Journal|May 5, 1979
Teratomas of the ovaryE S Newlands, R H Begent, G J Rustin, et al.
Lancet (London, England)|June 13, 1981
Cytotoxic drugs and sterilityG J Rustin, K D Bagshawe, E S Newlands, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Single agent activity of carboplatin in patients with previously untreated non-seminomatous germ cell tumoursS M O'Reilly, G J Rustin, D B Smith, et al.
British Journal of Cancer|June 1, 1993
Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. III: Cytokine studiesC Haworth, S M O'Reilly, E Chu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Fertility after chemotherapy for ovarian germ cell tumorsG J Rustin, E S Newlands, R H Begent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group StudyG J Rustin, A E Nelstrop, M K Tuxen, et al.
British Journal of Obstetrics and Gynaecology|July 1, 1982
Potential for cure in metastatic ovarian teratomas and dysgerminomasE S Newlands, R H Begent, G J Rustin, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
British Journal of Cancer|October 25, 2000
Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumoursM P Napier, A Naraghi, T J Christmas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 1, 1997
FaFEC: a novel regimen for advanced ovarian cancerM Bower, K Goodchild, H Evans, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Treatment of advanced malignant melanoma with interferon alpha and etretinateG J Rustin, S Dische, S T de Garis, et al.
British Medical Journal|May 5, 1979
Teratomas of the ovaryE S Newlands, R H Begent, G J Rustin, et al.
Lancet (London, England)|June 13, 1981
Cytotoxic drugs and sterilityG J Rustin, K D Bagshawe, E S Newlands, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Single agent activity of carboplatin in patients with previously untreated non-seminomatous germ cell tumoursS M O'Reilly, G J Rustin, D B Smith, et al.
British Journal of Cancer|June 1, 1993
Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. III: Cytokine studiesC Haworth, S M O'Reilly, E Chu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Fertility after chemotherapy for ovarian germ cell tumorsG J Rustin, E S Newlands, R H Begent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group StudyG J Rustin, A E Nelstrop, M K Tuxen, et al.
British Journal of Obstetrics and Gynaecology|July 1, 1982
Potential for cure in metastatic ovarian teratomas and dysgerminomasE S Newlands, R H Begent, G J Rustin, et al.
Pageof 16